期刊文献+

“中孕期母血清学产前筛查技术标准”解读 被引量:9

下载PDF
导出
摘要 唐氏综合征是最常见的染色体病,在活产婴儿中的发生率1/600~1/800[1-5]。患儿将终生罹患智能发育迟缓、多发畸形、生育障碍等严重的结构和功能缺陷,给家庭和社会带来沉重的负担[6]。Merkatz等[7]首先发现孕中期孕妇血清甲胎蛋白(AFP)的降低与唐氏综合征妊娠有关,此后又相继发现游离雌三醇(uE3)降低、人绒毛膜促性腺激素β亚基(β-hCG)升高、妊娠相关血浆蛋白A(PAPP-A)降低、
出处 《中国产前诊断杂志(电子版)》 2012年第4期1-5,共5页 Chinese Journal of Prenatal Diagnosis(Electronic Version)
基金 国家十一五科技支撑计划重大项目(编号:2006BA105A08) 云南省科技计划社会发展项目(编号:2011CA017)资助
  • 相关文献

参考文献10

二级参考文献24

  • 1Hsu JJ, Shieh TT, Hsien FJ. Down syndrome screening in an Asian population using alpha-fetoprotein and free β-hCG: a report of the Taiwan Down syndrome screening group. Obstet Gynecol, 1996,87:943-947.
  • 2Wald NJ, Kennard A, Hackshaw A, et al. Antenatal screening for Down's syndrome. J Med Screen, 1997, 4:151-246.
  • 3Wald N J, Rodeck C, Hackshaw AK, et al. First and Second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS) . Health Techol Assess, 2003, 7 : 1-77.
  • 4Watt HC, Wald N J, Smith D, et al. Effect of allowing for ethnic group in prenatal screening for Down's syndrome. Prenat Diagn, 1996, 16:691-698.
  • 5O'brien JE, Dvorin E, Drugan A, et al. Race-ethnicity-specific variation in multiple-marker biochemical screening; alphafetoprotein, hCG, and estriol. Am J Obstet Gynecol, 1997, 89: 355-358.
  • 6Benn PA, Clive JM, Collins R. Medians for second-trimester maternal serum α-fetoprotein, human chorionic gonadotropin, and unconjugated estriol; differences between races or ethnic groups. Clin Chem, 1997, 43:333-337.
  • 7Lam YH, Ghosh A, Tang MH, et al. Second-trimester maternal serum alpha-fetoprotein and human chrionic gonadotrophin screening for Down's syndrome in Hong Kong. Prenat Diagn, 1998.18:585-589.
  • 8Chao AS, Chao LC, Wu CD, et al. Second trimester maternal serum screening using alpha fetoprotein, free beta human chorionic gonadotropin and maternal age specific risk : result of chromosomal abnormalities detected in screen positive for Down syndrome in an Asian population. Acta Obstet Gynecol, 1999,78:393-397.
  • 9Jou HJ, Shyu MK, Chen SM, et al. Maternal serum screening for Down syndrome by using alpha-fetoprotein and human chorionic gnadotrophin in an Asian population. Fetal Diagn Ther, 2000, 15:108-111.
  • 10Lau TK, Fung HY, Rogers MS, et al. Racial variation in incidence of trisomy 21 : survey of 57 742 Chinese deliveries. Am J Med Genet, 1998, 75:386-388.

共引文献197

同被引文献86

  • 1胎儿常见染色体异常与开放性神经管缺陷的产前筛查与诊断技术标准 第1部分:中孕期母血清学产前筛查[J].中国产前诊断杂志(电子版),2011(3):42-47. 被引量:19
  • 2朱宝生,焦存仙,朱姝,董旭东,胡云英,刘云霞,冯怀英,刘娟,唐新华,张云霞,王瑞红,祝杏珍,章晓梅.唐氏综合征发生率及其受产前筛查干预的研究[J].中华妇幼临床医学杂志(电子版),2005,1(1):20-22. 被引量:31
  • 3王雪方,施云凤.杭州地区8516例孕中期妇女产前筛查回顾性分析[J].中国优生与遗传杂志,2006,14(7):51-52. 被引量:20
  • 4陆国辉,杜传书主编.产前遗传学诊断[M].广州:广东科技出版社,2002:84.
  • 5Malone FD,Canick JA,Ball RH. First-trimester and second-trimester screening,or both,for Down's syndrome[J].New England Journal of Medicine,2005,(19):2001-2011.
  • 6Ball RH,Caughey AB,Malone FD. First and second trimester evaluation of risk(faster) research consortium.first-and second-trimester evaluation of risk for Down's syndrome[J].OBSTETRICS AND GYNECOLOGY,2007,(01):10-17.
  • 7Wald NJ,Rodeck C,Hackshaw AK. Suruss in perspective[J].British Journal of Obstefrics and Gynaecology,2004,(06):521-531.
  • 8Hsu JJ,Hsieh TF,Soong YK. The influence of maternal weight correction formulas in asian Down syndrome screening using alpha-fetoprotein and free beta-human chorionic gonadortropin[J].J Matem Fetal Investig,1998,(02):66-70.
  • 9段涛;胡娅莉;吕时铭.产前诊断[M]北京:人民卫生出版社,2010255-263.
  • 10Wald NJ,Rodeck C,Hackshaw AK. First and second trimester antenatal screening for Down's syndrome:the results of the serum,urine and ultrasound screening study (SURUSS)[J].HEALTH TECHNOLOGY ASSESSMENT,2003,(11):1-77.

引证文献9

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部